| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.1M | +39.1% |
| SG&A Expense | $399K | -7.2% |
| Operating Income | -$2.1M | -4.1% |
| Pre-tax Income | -$1.6M | +17.0% |
| Income Tax | $0 | — |
| Net Income | -$1.6M | +17.0% |
| EPS (Basic) | -$0.02 | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $688K | -68.9% |
| Total Assets | $718K | -68.0% |
| Current Liabilities | $302K | +146.6% |
| Stockholders' Equity | $415K | -80.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | -9.9% |
| Investing Cash Flow | $5K | — |
| Financing Cash Flow | $0 | -100.0% |